No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1344 |
4. Check minimum number of eventsNone |
1344 |
5. Include endpointsNone |
1344 |
6. Filter based on genotype QC (FinnGen only) |
1231 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Hypogonadotropic hypogonadism
based on the number of shared cases.
Similar with more cases:
- Hypopituitarism
- Exclusions for E4_PCOS_BROAD
- Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT
- Disorders of other endocrine glands
- Exclusions for E4_PCOS_CONSORTIUM
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1231 | 74 | 1157 |
| Unadjusted period prevalence (%) | 0.50 | 0.03 | 0.53 |
| Median age at first event (years) | 49.40 | 31.59 | 50.53 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1265
- Matched controls
- 12650
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
96.4
307.7
1038
573
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
4503599627370496.0
307.7
1263
77
101
Kela drug reimbursment
Anterior pituitary hypofunction
168.9
307.7
371
31
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
72.2
307.7
231
39
E29.1
ICD-10 Finland
Testicular hypofunction
15.7
265.5
248
194
Y28
ICPC
Limited function/disability (Y)
30.8
192.3
128
46
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
12.8
171.3
176
158
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
33.0
167.9
109
36
WVA30, ,
SPAT
6.8
128.2
223
384
E23.00
ICD-10 Finland
Panhypopituitarism
60.8
123.4
69
12
A55
ICPC
General and Unspecified, Local injection/infiltration
12.9
122.8
123
105
T99
ICPC
Endocr/metab/nutrit disease other
16.6
120.9
104
68
E22.1
ICD-10 Finland
Hyperprolactinaemia
69.6
120.8
66
10
121
Kela drug reimbursment
Severe hypofunction of sexual glands
15.6
113.7
101
70
G47.3
ICD-10 Finland
Sleep apnoea
3.7
112.7
626
2666
H02AB09
ATC
hydrocortisone; systemic
12.1
106.0
110
99
A50
ICPC
General and Unspecified, Medication/prescr/renewal
7.0
93.6
152
241
H03AA01
ATC
levothyroxine sodium; systemic
4.3
88.5
276
778
G03GA01
ATC
chorionic gonadotrophin; parenteral
18.7
85.8
69
39
N04BC06
ATC
cabergoline; oral
35.2
85.2
54
16
N06AX16
ATC
venlafaxine; oral
3.8
82.3
313
1011
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
40.0
81.7
50
13
T28
ICPC
Limited function/disability (T)
16.2
65.2
56
36
E29.9
ICD-10 Finland
Testicular dysfunction, unspecified
16.4
64.4
55
35
N06AX21
ATC
duloxetine; oral
3.7
64.1
234
727
N06AX11
ATC
mirtazapine; oral
2.7
62.2
541
2751
N06AX26
ATC
vortioxetine; oral
3.9
61.7
204
591
E66.01
ICD-10 Finland
Obesity due to excess calories
3.9
61.5
207
607
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.1
55.1
279
1055
R53
ICD-10 Finland
Malaise and fatigue
2.8
54.8
380
1705
N05AH04
ATC
quetiapine; oral
2.8
54.6
366
1613
R5140
NOMESCO Finland
Monitoring the use of the aid
3.1
54.3
276
1046
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.5
53.4
545
2941
N06AB10
ATC
escitalopram; oral
2.7
50.8
366
1666
N05BA04
ATC
oxazepam; oral
2.7
50.6
364
1654
N06AX12
ATC
bupropion; oral
3.3
46.4
199
678
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
4.2
46.3
130
332
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.8
45.9
156
457
E66.8
ICD-10 Finland
Other obesity
4.3
44.3
120
298
E66.00
ICD-10 Finland
Metabolic syndrome
3.9
43.4
139
390
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.9
40.1
124
339
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
91.2
40.0
44
5
N03AX16
ATC
[U] pregabalin
2.5
38.9
320
1528
D75.1
ICD-10 Finland
Secondary polycythaemia
10.3
38.2
43
43
E23.05
ICD-10 Finland
Lack of TSH
73.9
38.2
43
6
N05CF02
ATC
zolpidem; oral
2.6
37.8
262
1151
N05CF01
ATC
zopiclone; oral
2.3
36.8
396
2118
N03AE01
ATC
clonazepam; systemic
3.8
36.7
119
336
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
8.8
36.3
46
54
Y08
ICPC
Sexual function sympt/compl male
9.8
36.1
42
44
N03AX09
ATC
lamotrigine; oral
3.6
35.8
124
366
N03AX12
ATC
[U] gabapentin; oral
2.6
35.1
238
1032
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
34.8
241
1056
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
33.4
331
1701
N06AX22
ATC
agomelatine; oral
5.3
32.8
68
135
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.2
32.5
143
491
L02BG04
ATC
letrozole; oral
7.5
32.4
47
65
N48.4
ICD-10 Finland
Impotence of organic origin
3.7
32.2
106
302
N05BA12
ATC
alprazolam; oral
2.9
31.3
160
598
N06AB04
ATC
citalopram; systemic
2.4
31.2
269
1298
N02AX02
ATC
tramadol; systemic, rectal
2.0
30.9
582
3790
I10
ICD-10 Finland
Essential (primary) hypertension
2.0
30.7
699
4855
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.7
29.8
99
284
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.8
29.6
96
271
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.8
29.5
159
610
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
58.2
29.2
34
6
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
29.0
300
1558
N06AB06
ATC
sertraline; oral
2.6
28.7
187
791
M03BX02
ATC
tizanidine; oral
2.0
28.1
853
6448
N02BF02
ATC
pregabalin; oral
3.2
28.1
121
409
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.0
27.7
81
212
T29
ICPC
Endocr/metab/nutr sympt/compl other
6.4
27.6
46
74
C07AA05
ATC
propranolol; systemic
2.2
27.4
278
1429
M54.5
ICD-10 Finland
Low back pain
1.9
27.2
512
3293
N91.1
ICD-10 Finland
Secondary amenorrhoea
27.2
27.2
37
14
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
27.0
189
826
L03
ICPC
Low back symptom/complaint
2.0
26.8
380
2216
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
26.4
606
4148
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
26.3
265
1357
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
26.0
627
4350
A02BC02
ATC
pantoprazole; systemic
1.9
26.0
816
6159
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
26.0
227
1095
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.8
25.9
137
520
-50
ICPC
Medication/prescr/renewal
4.4
25.8
66
156
M01AE02
ATC
naproxen; oral, rectal
1.9
25.7
717
5204
M01AH05
ATC
etoricoxib; oral
1.9
25.5
858
6603
R51.80
ICD-10 Finland
Headache
2.3
25.3
217
1038
SPAT1254
SPAT
Administration of medicine
2.6
25.0
166
706
N05BA01
ATC
diazepam; systemic, rectal
2.5
24.9
181
804
N62
ICD-10 Finland
Hypertrophy of breast
5.4
24.8
49
93
WX723
NOMESCO Finland
CPAP therapy
2.9
24.4
119
432
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
24.1
232
1162
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.5
23.8
157
666
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.1
23.7
286
1563
G03FB08
ATC
dydrogesterone and estrogen; systemic
20.0
23.5
35
18
R52.2
ICD-10 Finland
Other chronic pain
3.9
23.5
70
186
N02BF01
ATC
gabapentin; oral
2.6
23.3
149
622
L02BG03
ATC
anastrozole; oral
28.8
23.2
31
11
A10BA02
ATC
metformin; oral
2.0
23.1
340
1992
A02BC05
ATC
esomeprazole; systemic
1.8
23.0
482
3166
N06AA09
ATC
amitriptyline; systemic
3.0
23.0
105
367
R06.0
ICD-10 Finland
Dyspnoea
2.0
22.7
296
1660
J01AA02
ATC
doxycycline; systemic
1.9
22.7
920
7370
P19
ICPC
Drug abuse
5.6
22.5
43
79
P06
ICPC
Sleep disturbance
2.2
22.3
216
1083
N06AB05
ATC
paroxetine; oral
3.0
22.3
104
368
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.1
21.8
233
1212
N05CD07
ATC
temazepam; oral
2.8
21.7
117
447
R03AC02
ATC
salbutamol; inhalant
1.8
21.7
655
4772
Y29
ICPC
Genital symptom/complaint male other
6.1
21.3
37
62
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.6
21.3
130
530
A10BJ02
ATC
liraglutide; parenteral
4.1
21.3
60
153
N06AB03
ATC
fluoxetine; oral
2.4
21.1
153
676
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
20.5
164
757
SPAT1310
SPAT
Counselling related to known health issue
1.9
20.4
341
2071
N02BE01
ATC
paracetamol; systemic, rectal
2.2
20.4
1083
9290
M79.1
ICD-10 Finland
Myalgia
2.2
20.4
199
998
L08
ICPC
Shoulder symptom/complaint
1.9
20.3
294
1705
M79.6
ICD-10 Finland
Pain in limb
1.8
20.0
523
3632
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
7.9
19.6
27
35
N06BA04
ATC
methylphenidate; oral
3.1
19.5
83
278
P76
ICPC
Depressive disorder
2.6
19.4
114
456
M48.0
ICD-10 Finland
Spinal stenosis
2.6
19.3
123
512
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
19.2
348
2164
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
6.1
19.1
33
55
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.9
19.0
93
337
N02AA05
ATC
oxycodone; systemic
2.2
18.8
182
909
C07AB07
ATC
bisoprolol; oral
1.7
18.7
481
3306
SPAT1216
SPAT
Assessment of functional ability
2.5
18.7
127
544
F51.0
ICD-10 Finland
Nonorganic insomnia
2.0
18.5
249
1402
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
18.5
232
1275
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
44.7
18.3
22
5
R06.5
ICD-10 Finland
Mouth breathing
2.1
18.1
183
928
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.0
18.0
52
135
Z01.2
ICD-10 Finland
Dental examination
1.7
17.9
588
4305
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
17.9
534
3812
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
7.4
17.8
26
36
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
17.8
541
3881
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
17.7
303
1843
XCK00
NOMESCO Finland
Perimetry
3.5
17.7
63
189
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.0
17.6
79
273
G04CA01
ATC
alfuzosin; oral
2.0
17.6
228
1267
R01AD12
ATC
fluticasone furoate; nasal
1.7
17.4
410
2739
J01DB01
ATC
cefalexin; oral
1.9
17.4
1046
9006
C09CA06
ATC
candesartan; oral
1.8
17.3
298
1815
C08CA01
ATC
amlodipine; oral
1.7
17.3
400
2659
WX722
NOMESCO Finland
PEEP
2.9
17.2
84
304
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
17.0
437
2986
N05BE01
ATC
buspirone; oral
3.3
17.0
64
199
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
16.8
331
2097
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.1
16.8
169
855
F60.5
ICD-10 Finland
Anankastic personality disorder
5.9
16.7
30
52
R01AD09
ATC
mometasone; nasal
1.7
16.6
549
4002
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.9
16.6
248
1443
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.5
16.6
111
472
Y99
ICPC
Genital disease male other
13.6
16.5
28
21
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
4.1
16.3
45
113
N04BC05
ATC
pramipexole; oral
2.8
16.1
84
316
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
4.0
16.0
46
119
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
16.0
311
1961
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
15.9
358
2352
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
12.4
15.9
28
23
N06AG02
ATC
moclobemide; oral
3.2
15.9
65
213
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
15.9
150
740
T90
ICPC
Diabetes non-insulin dependent
1.8
15.8
280
1716
G02CB03
ATC
cabergoline; oral
60.8
15.8
18
*
M81.9
ICD-10 Finland
Osteoporosis, unspecified
5.4
15.7
31
59
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
26.7
15.6
21
8
SPAT1312
SPAT
General health counselling
1.7
15.6
327
2104
J01FA10
ATC
azithromycin; systemic
1.6
15.6
699
5467
R01BA52
ATC
pseudoephedrine, combinations; oral
1.8
15.6
318
2031
L01
ICPC
Neck symptom/complaint
2.0
15.6
187
1009
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
15.4
314
2003
R52.1
ICD-10 Finland
Chronic intractable pain
6.5
15.4
25
39
WX780
NOMESCO Finland
Remote monitoring CPAP
2.4
15.4
107
463
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.3
15.3
117
528
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.7
15.3
320
2057
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
15.2
238
1403
E23.03
ICD-10 Finland
Lack of ACTH
45.6
15.1
18
*
N46
ICD-10 Finland
Male infertility
3.1
15.1
63
209
E03.89
ICD-10 Finland
Other specified hypothyroidism
4.5
15.0
37
85
N06AA12
ATC
doxepin; systemic
3.2
15.0
60
194
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
15.0
294
1854
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
14.9
387
2633
C08CA13
ATC
lercanidipine; oral
2.1
14.9
143
709
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.8
14.9
78
294
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.8
14.8
46
126
R01AD58
ATC
fluticasone, combinations; nasal
1.7
14.8
339
2231
S18
ICPC
Laceration/cut
1.6
14.8
532
3928
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.7
14.6
81
314
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.2
14.6
138
680
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
6.4
14.6
24
38
F34.1
ICD-10 Finland
Dysthymia
3.0
14.6
65
224
A04
ICPC
Weakness/tiredness general
2.1
14.6
159
828
A02BC03
ATC
lansoprazole; oral
1.8
14.5
278
1740
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.5
14.4
96
407
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.8
14.4
44
119
F32.1
ICD-10 Finland
Moderate depressive episode
2.4
14.4
99
426
T55
ICPC
Metabolic, Local injection/infiltration
12.7
14.4
25
20
L15
ICPC
Knee symptom/complaint
1.8
14.3
262
1616
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
14.1
325
2138
G03DB01
ATC
dydrogesterone; oral
4.4
14.1
35
81
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
14.0
866
7229
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
4.2
14.0
37
90
P03
ICPC
Feeling depressed
2.1
13.9
143
727
J01FF01
ATC
clindamycin; systemic
1.7
13.9
327
2161
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
13.9
260
1612
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.9
13.9
67
241
N06AX18
ATC
reboxetine; oral
6.1
13.9
24
40
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
3.8
13.9
42
113
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.7
13.9
364
2477
N06AA10
ATC
nortriptyline; systemic
4.2
13.8
37
91
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
6.3
13.8
23
37
M54.2
ICD-10 Finland
Cervicalgia
2.2
13.7
118
560
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.8
13.7
68
249
R03BA05
ATC
fluticasone; inhalant
1.9
13.7
197
1128
N06AX03
ATC
mianserin; oral
3.0
13.7
60
205
SPAT1240
SPAT
Therapeutic discussion
2.1
13.6
144
740
H01AC01
ATC
somatropin; parenteral
14.9
13.6
22
15
M01AH01
ATC
celecoxib; oral
2.0
13.5
172
944
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.1
13.5
143
735
L17
ICPC
Foot/toe symptom/complaint
1.7
13.5
314
2067
G44.2
ICD-10 Finland
Tension-type headache
2.1
13.5
145
750
SPAT1229
SPAT
Assessment of need for aid
3.0
13.5
61
212
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.3
13.5
101
452
M25.5
ICD-10 Finland
Pain in joint
1.6
13.4
393
2746
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.9
13.3
189
1077
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.5
13.2
82
336
R4110, ,
SPAT
2.1
13.2
131
657
SFA10
NOMESCO Finland
One-surface restoration
1.6
13.1
708
5685
A10BJ06
ATC
semaglutide; parenteral
2.4
13.1
95
419
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
13.0
217
1299
S55
ICPC
Skin, Local injection/infiltration
9.5
13.0
26
28
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
13.0
397
2799
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
12.9
380
2652
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
12.9
307
2030
M01AB05
ATC
diclofenac; systemic, rectal
1.6
12.9
828
6903
D35.31
ICD-10 Finland
Cyst in Rathke's pocket
50.5
12.9
15
*
E03
ICD-10 Finland
Other hypothyroidism
3.3
12.8
48
149
H02AB06
ATC
prednisolone; systemic
1.6
12.8
513
3847
R86.1
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of hormones
14.2
12.8
21
15
AA1AD
NOMESCO Finland
CT of head and brain
1.7
12.7
289
1888
SPAT1377
SPAT
Polysomnography
3.0
12.6
55
187
EB1VA, ,
NOMESCO Finland
1.7
12.6
243
1516
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
4.7
12.6
29
63
XKD00
NOMESCO Finland
Uroflowmetry
1.8
12.6
192
1117
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
12.6
198
1164
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.1
12.5
129
657
A29
ICPC
General symptom/complaint other
2.0
12.5
138
721
WVA20, ,
SPAT
3.0
12.4
55
189
F32
ICD-10 Finland
Depressive episode
2.4
12.4
84
359
WX290
NOMESCO Finland
Other blockage of nerve
1.5
12.4
681
5463
R03BA08
ATC
ciclesonide; inhalant
2.2
12.3
101
470
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.3
12.3
93
418
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.3
12.3
92
412
J01CA04
ATC
amoxicillin; systemic
1.7
12.2
1002
8788
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
37.9
12.2
15
*
301
Kela drug reimbursment
Growth hormone
37.9
12.2
15
*
N03AG01
ATC
valproic acid; systemic, rectal
2.3
12.2
98
452
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
12.2
500
3759
P01
ICPC
Feeling anxious/nervous/tense
1.9
12.0
166
935
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
12.0
906
7765
J34.2
ICD-10 Finland
Deviated nasal septum
2.1
11.9
121
613
SPAT1301
SPAT
No procedures
1.7
11.9
289
1918
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
11.9
923
7953
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
11.9
655
5238
N06AX05
ATC
trazodone; oral
3.5
11.9
41
121
R42
ICD-10 Finland
Dizziness and giddiness
1.8
11.9
203
1223
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
11.8
704
5720
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.2
11.7
45
142
SPAT1263
SPAT
Sampling
1.6
11.7
428
3129
F31.8
ICD-10 Finland
Other bipolar affective disorders
3.3
11.7
43
132
N05AX12
ATC
aripiprazole; systemic
2.3
11.6
87
390
G03GA02
ATC
human menopausal gonadotrophin; parenteral
11.2
11.6
21
19
SPAT1262
SPAT
Handing over of treatment supplies
1.8
11.5
187
1108
UKC02
NOMESCO Finland
Cystoscopy
1.9
11.5
158
889
D82
ICPC
Teeth/gum disease
1.5
11.5
475
3565
C10AA05
ATC
atorvastatin; oral
1.5
11.5
440
3249
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
11.3
286
1914
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.7
11.3
264
1733
A46
ICD-10 Finland
Erysipelas
1.8
11.3
190
1139
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
11.2
140
764
E23.06
ICD-10 Finland
Empty sella
25.3
11.1
15
6
T82
ICPC
Obesity
2.6
11.1
64
253
J45
ICD-10 Finland
Asthma
2.1
11.1
114
579
R03DC03
ATC
montelukast; oral
1.8
11.1
175
1028
IFC01, ,
SPAT
11.3
11.1
20
18
L28
ICPC
Limited function/disability (L)
1.9
11.1
139
759
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.7
11.0
258
1692
M02AA07
ATC
piroxicam; topical
1.6
11.0
327
2274
E66
ICD-10 Finland
Obesity
2.3
11.0
84
379
T50
ICPC
Metabolic, Medication/prescr/renewal
14.0
11.0
18
13
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
2.4
11.0
77
335
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
11.0
90
419
J05AB01
ATC
aciclovir; systemic
1.7
10.9
204
1258
E23
ICD-10 Finland
Hypofunction and other disorders of pituitary gland
43.7
10.9
13
*
A02BC01
ATC
omeprazole; systemic
1.7
10.9
239
1540
A99
ICPC
Disease/condition unspecnature/site
2.1
10.9
114
583
ZXC86
NOMESCO Finland
Use of endoscopic device
9.7
10.8
21
22
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.7
10.8
59
228
3051, ,
Kela drug reimbursment
4.8
10.7
24
51
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
18.0
10.7
16
9
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.3
10.7
82
371
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
10.7
116
602
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
10.6
571
4505
R05FB02
ATC
cough suppressants and expectorants; systemic
1.6
10.6
327
2291
T83
ICPC
Overweight
4.0
10.6
30
77
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.6
10.5
321
2244
R01AD08
ATC
fluticasone; nasal
1.6
10.5
331
2331
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
10.4
120
635
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
2.8
10.4
52
191
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
10.4
69
292
M05BA04
ATC
alendronic acid; oral
3.1
10.4
42
137
C07AB12
ATC
nebivolol; oral
2.9
10.4
47
164
G62.8
ICD-10 Finland
Other specified polyneuropathies
5.2
10.3
21
41
Z00.0
ICD-10 Finland
General medical examination
1.7
10.3
214
1358
C10AA07
ATC
rosuvastatin; oral
1.5
10.3
390
2858
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.9
10.3
47
165
R02
ICPC
Shortness of breath/dyspnoea
2.0
10.2
123
661
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
4.2
10.2
27
66
NA3BG, ,
SPAT
2.3
10.1
79
360
DJD20
NOMESCO Finland
Plastic repair of septum of nose
2.2
10.1
86
406
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
4.4
10.1
25
58
R06AE07
ATC
cetirizine; oral
1.5
10.1
468
3575
N05AN01
ATC
lithium; oral
2.8
10.1
49
178
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
3.3
10.1
38
119
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.0
10.0
117
623
R04
ICPC
Breathing problem other
2.7
10.0
52
196
J01FA09
ATC
clarithromycin; systemic
1.5
9.8
341
2447
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
9.8
264
1787
J01MA02
ATC
ciprofloxacin; systemic
1.5
9.8
409
3052
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.5
9.8
33
96
J02AC02
ATC
itraconazole; systemic
1.8
9.7
164
981
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.8
9.7
167
1005
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
9.7
331
2367
C09CA01
ATC
losartan; oral
1.6
9.7
256
1726
C05AA08
ATC
fluocortolone; rectal, topical
1.8
9.7
140
800
F11.23
ICD-10 Finland
Addiction-induced dependence is currently independent but uses aversion-inducing medication
55.4
9.7
11
*
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.2
9.6
78
361
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.3
9.6
35
107
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
9.6
111
589
R29
ICPC
Respiratory symptom/complaint other
2.2
9.6
84
402
TAB00
NOMESCO Finland
Lumbar puncture
2.5
9.6
60
248
Y50
ICPC
Male Genital, Medication/prescr/renewal
15.2
9.5
15
10
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.0
9.5
108
570
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
2.0
9.4
107
564
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
17.7
9.4
14
8
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
9.4
476
3686
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.9
9.4
121
666
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.1
9.4
86
419
ZX114, ,
SPAT
4.9
9.3
20
41
OAB72
NOMESCO Finland
Weight control and weight loss guidance
4.7
9.3
21
45
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
9.3
118
646
J02AC01
ATC
fluconazole; systemic
1.6
9.3
240
1608
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
9.6
9.3
18
19
A98
ICPC
Health maint/preventive medicine
3.2
9.3
1238
11817
C10AC01
ATC
colestyramine; oral
3.3
9.2
34
105
N06AB08
ATC
fluvoxamine; oral
3.0
9.2
39
131
SCA01
NOMESCO Finland
Preventive oral health care, short
1.5
9.2
329
2374
ZX114
NOMESCO Finland
Intramuscular
4.3
9.1
23
54
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.8
9.1
44
159
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
9.1
350
2561
J01CF05
ATC
flucloxacillin; systemic
2.0
9.1
102
536
ZYC01
NOMESCO Finland
Remote contact by phone
2.1
9.1
91
459
E30.09
ICD-10 Finland
Delayed puberty NOS
15.7
9.0
14
9
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
9.1
9.0
18
20
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.5
9.0
338
2461
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
2.0
9.0
101
531
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
8.9
248
1690
M01AC06
ATC
meloxicam; systemic, rectal
1.5
8.9
353
2600
G03GA05
ATC
follitropin alfa; parenteral
8.0
8.9
19
24
A10BH01
ATC
sitagliptin; oral
2.0
8.8
96
498
A06AD11
ATC
lactulose; oral
1.9
8.8
109
591
R03BA02
ATC
budesonide; inhalant
1.7
8.8
179
1127
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.3
8.8
68
309
N40
ICD-10 Finland
Hyperplasia of prostate
1.6
8.8
256
1762
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
9.6
8.8
17
18
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
3.1
8.7
36
119
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
2.6
8.7
48
186
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.7
8.7
45
169
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.6
8.7
28
79
OAB50
NOMESCO Finland
Delivery of care equipment and instruction on their use
3.5
8.7
29
84
P20
ICPC
Memory disturbance
2.2
8.6
71
331
XG466
NOMESCO Finland
Sleep oxymetry
2.6
8.6
49
193
R96
ICPC
Asthma
2.1
8.6
84
419
SPAT1153
SPAT
Removal of sutures
1.5
8.6
284
2010
C03CA01
ATC
furosemide; systemic
1.7
8.6
180
1143
L86
ICPC
Back syndrome with radiating pain
2.2
8.6
69
319
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
8.5
246
1688
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.0
8.5
97
512
102
Kela drug reimbursment
Diabetes insipidus
27.7
8.5
11
*
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
8.5
111
614
N05AA02
ATC
levomepromazine; systemic
2.3
8.5
64
288
SPAT1360
SPAT
Extensive global examination
2.3
8.5
61
269
A02BC04
ATC
rabeprazole; oral
1.9
8.4
100
535
J01FA06
ATC
roxithromycin; oral
1.5
8.4
388
2937
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.9
8.4
106
579
R03AK08
ATC
formoterol and beclometasone; inhalant
2.5
8.4
51
208
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
3.3
8.4
31
96
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
+∞
8.3
8
*
G04CA02
ATC
tamsulosin; oral
1.5
8.3
286
2040
N97.0
ICD-10 Finland
Female infertility associated with anovulation
10.8
8.3
15
14
R06AX22
ATC
ebastine; oral
1.7
8.3
176
1121
R52.9
ICD-10 Finland
Pain, unspecified
1.8
8.3
120
686
F31
ICD-10 Finland
Bipolar affective disorder
3.5
8.2
28
82
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.3
8.2
60
266
R60.0
ICD-10 Finland
Localized oedema
1.9
8.2
111
620
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.8
8.2
119
680
R35
ICD-10 Finland
Polyuria
2.1
8.2
81
406
E23.2
ICD-10 Finland
Diabetes insipidus
14.6
8.2
13
9
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.4
8.2
653
5451
A10BK01
ATC
dapagliflozin; oral
1.9
8.2
102
556
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.2
8.1
67
313
Y05
ICPC
Scrotum/testis sympt/compl other
3.2
8.1
31
98
S01GX01
ATC
cromoglicic acid; ophthalmic
1.6
8.1
195
1281
L10
ICPC
Elbow symptom/complaint
2.0
8.1
88
457
J01DA01
ATC
[U] cefalexin
1.4
8.1
662
5546
E29.8
ICD-10 Finland
Other testicular dysfunction
11.8
8.1
14
12
Z31.5
ICD-10 Finland
Genetic counselling
2.4
8.1
56
243
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.5
8.1
51
212
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
3.7
8.0
25
69
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.5
8.0
383
2914
J01AA04
ATC
lymecycline; systemic
1.7
8.0
146
892
Z3231
NOMESCO Finland
Registered nurse
1.5
8.0
274
1951
K03.80
ICD-10 Finland
Irradiated enamel
2.2
8.0
64
296
IHZ05, ,
SPAT
2.2
7.9
67
317
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
7.9
244
1700
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
7.9
187
1225
C03AA03
ATC
hydrochlorothiazide; oral
2.3
7.9
56
246
R05FA02
ATC
opium derivatives and expectorants; systemic
1.5
7.9
363
2743
AB5CT
NOMESCO Finland
Blockage of nerv root with CT guidance
6.1
7.9
20
33
A07AA02
ATC
nystatin; oral
2.6
7.8
43
167
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.5
7.8
48
197
WZA90
NOMESCO Finland
Other medical or dental certificate
1.5
7.8
266
1892
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
9.5
7.8
15
16
SFA30
NOMESCO Finland
Three-surface restoration
1.4
7.8
521
4208
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
7.8
261
1850
M01AE01
ATC
ibuprofen; systemic, rectal
1.7
7.8
1145
10696
M43.1
ICD-10 Finland
Spondylolisthesis
2.6
7.7
42
162
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.8
7.7
108
610
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.7
7.7
163
1036
XG405
NOMESCO Finland
Education on PEF monitoring
3.9
7.7
22
57
N91.0
ICD-10 Finland
Primary amenorrhoea
45.3
7.7
9
*
NBG10
NOMESCO Finland
Acromioplastia
3.6
7.7
25
71
K02.1
ICD-10 Finland
Caries of dentine
1.4
7.7
766
6610
K60.2
ICD-10 Finland
Anal fissure, unspecified
3.2
7.7
29
91
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
3.2
7.7
29
91
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.2
7.7
65
307
A10BK03
ATC
empagliflozin; oral
1.8
7.7
125
740
M54.6
ICD-10 Finland
Pain in thoracic spine
1.9
7.6
93
503
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.9
7.6
101
562
R39.1
ICD-10 Finland
Other difficulties with micturition
2.4
7.6
49
206
R94.7
ICD-10 Finland
Abnormal results of other endocrine function studies
11.9
7.6
13
11
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.5
7.6
243
1705
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.6
7.6
43
170
L02BA01
ATC
tamoxifen; oral
6.2
7.6
19
31
G03GA06
ATC
follitropin beta; parenteral
8.9
7.5
15
17
KE1BG
NOMESCO Finland
MRI of prostate
3.8
7.5
22
58
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
7.5
265
1895
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.8
7.5
123
729
L14
ICPC
Leg/thigh symptom/complaint
2.0
7.5
80
413
C09DA06
ATC
candesartan and diuretics; oral
2.0
7.5
79
406
J01MA12
ATC
levofloxacin; systemic
1.6
7.5
180
1182
P74
ICPC
Anxiety disorder/anxiety state
2.2
7.5
61
284
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
2.9
7.5
33
114
R06AX27
ATC
desloratadine; oral
1.5
7.5
317
2354
R05
ICPC
Cough
1.5
7.4
226
1566
H53.4
ICD-10 Finland
Visual field defects
3.6
7.4
24
68
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
3.6
7.4
24
68
Z71.8
ICD-10 Finland
Other specified counselling
1.4
7.4
358
2722
F52.2
ICD-10 Finland
Failure of genital response
2.1
7.4
69
339
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
6.0
7.4
19
32
IFA37
NOMESCO Finland
Ketamine treatment
13.4
7.4
12
9
J45.8
ICD-10 Finland
Mixed asthma
3.0
7.4
31
104
A03
ICPC
Fever
1.5
7.4
219
1510
R06AE09
ATC
levocetirizine; oral
1.7
7.4
155
984
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.4
7.3
384
2964
CS494
NOMESCO Finland
Other visual field testing
3.1
7.3
29
94
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
6.9
7.3
17
25
F41.3
ICD-10 Finland
Other mixed anxiety disorders
3.4
7.3
25
74
N06AA06
ATC
trimipramine; systemic
3.0
7.3
31
105
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.3
7.3
54
242
A10BG03
ATC
pioglitazone; oral
2.9
7.3
33
116
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
2.8
7.2
34
122
SFA20
NOMESCO Finland
Two-surface restoration
1.4
7.2
741
6399
X58
ICD-10 Finland
Exposure to other specified factors
1.5
7.1
223
1555
XA420
NOMESCO Finland
Extensive sleep examination
3.8
7.1
21
56
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
4.1
7.1
19
47
SPAT1283
SPAT
Restricted health certificate
1.5
7.1
212
1464
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.7
7.1
136
844
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.7
7.1
136
844
K03.64
ICD-10 Finland
Dental calculus supragingival
1.4
7.0
384
2981
M80.5
ICD-10 Finland
Idiopathic osteoporosis with pathological fracture
10.1
7.0
13
13
P01AB01
ATC
metronidazole; oral, rectal
1.4
7.0
341
2592
N05AH03
ATC
olanzapine; systemic
1.8
7.0
104
599
UJF32
NOMESCO Finland
Coloscopy
1.5
7.0
231
1630
L12
ICPC
Hand/finger symptom/complaint
1.6
7.0
174
1153
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.2
6.9
56
260
A10BX09
ATC
[U] dapagliflozin
5.9
6.9
18
31
SGA01
NOMESCO Finland
Emergency treatment
1.5
6.9
236
1675
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
4.0
6.9
19
48
M81.5
ICD-10 Finland
Idiopathic osteoporosis
13.9
6.9
11
8
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
2.5
6.9
41
166
R4190
NOMESCO Finland
Nutritional therapy
2.2
6.9
54
248
F11.1
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, harmful use
8.3
6.8
14
17
E0000UV, ,
ATC
1.4
6.8
410
3234
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
6.8
120
727
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.6
6.8
145
924
GX2D5
NOMESCO Finland
Sleep oximetry
4.3
6.8
17
40
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
6.7
230
1632
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
6.7
146
934
R04.0
ICD-10 Finland
Epistaxis
2.0
6.7
72
373
A01
ICPC
Pain general/multiple sites
1.8
6.7
93
525
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
6.7
77
409
160
Kela drug reimbursment
exenatide
3.0
6.7
28
94
205
Kela drug reimbursment
Chronic hypertension
1.6
6.7
177
1189
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
2.6
6.7
37
145
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.3
6.7
49
219
M01AG02
ATC
tolfenamic acid; oral, rectal
1.8
6.6
99
571
S29
ICPC
Skin symptom/complaint other
1.6
6.6
187
1273
J31.0
ICD-10 Finland
Chronic rhinitis
1.8
6.6
100
579
E29
ICD-10 Finland
Testicular dysfunction
7.9
6.6
14
18
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
2.9
6.6
29
100
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
2.4
6.6
42
176
M01AC01
ATC
piroxicam; systemic, rectal
1.7
6.5
111
665
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
6.5
99
574
R21
ICPC
Throat symptom/complaint
1.5
6.5
230
1643
R03BA01
ATC
beclometasone; inhalant
1.7
6.5
120
736
SDA03
NOMESCO Finland
Periodontal treatment
1.4
6.5
482
3927
SPAT1260
SPAT
Consultation of another employee
1.6
6.5
152
991
H53.2
ICD-10 Finland
Diplopia
2.5
6.5
40
165
R05
ICD-10 Finland
Cough
1.5
6.5
207
1448
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
6.2
6.5
16
26
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.9
6.5
79
428
D07AC13
ATC
mometasone; topical
1.4
6.5
291
2178
L90
ICPC
Osteoarthrosis of knee
2.3
6.5
47
209
M01AX05
ATC
glucosamine; oral
1.8
6.5
97
561
N29
ICPC
Neurological sympt/complt other
3.5
6.5
21
60
D07AD01
ATC
clobetasol; topical
1.6
6.4
155
1017
R25.1
ICD-10 Finland
Tremor, unspecified
2.8
6.4
30
107
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
6.4
651
5561
D35.30
ICD-10 Finland
Craniopharyngoma
70.2
6.4
7
*
EB4VA, ,
NOMESCO Finland
1.5
6.4
214
1510
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.1
6.4
58
282
-55
ICPC
Local injection/infiltration
7.4
6.4
14
19
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
6.4
106
631
H81
ICPC
Excessive ear wax
1.6
6.4
172
1159
F51
ICD-10 Finland
Nonorganic sleep disorders
2.1
6.4
62
310
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.7
6.4
32
119
N06BA12
ATC
lisdexamfetamine; oral
3.1
6.4
26
86
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.5
6.3
242
1755
F41.00
ICD-10 Finland
Moderate panic disorder
3.1
6.3
25
81
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
11.1
6.3
11
10
G02CB01
ATC
bromocriptine; systemic
11.1
6.3
11
10
OAB50, ,
SPAT
1.8
6.3
94
543
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
2.7
6.3
32
120
AA400
NOMESCO Finland
Electroconvulsive therapy
3.9
6.3
18
47
R06AX13
ATC
loratadine; oral
1.6
6.3
148
967
M821, E2304,
ICD-10 Finland
+∞
6.3
6
*
E23.6
ICD-10 Finland
Other disorders of pituitary gland
+∞
6.3
6
*
K03.66
ICD-10 Finland
Tooth plaque
1.8
6.2
91
522
F45.8
ICD-10 Finland
Other somatoform disorders
2.0
6.2
65
334
M01AB01
ATC
indometacin; systemic, rectal
2.0
6.2
66
341
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.1
6.2
57
279
SPAT1238
SPAT
Brief therapy
3.2
6.2
24
77
N02AJ13
ATC
tramadol and paracetamol; systemic
2.8
6.2
29
104
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.4
6.2
40
169
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
6.2
166
1118
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.8
6.1
85
480
NA3AA, ,
SPAT
2.1
6.1
53
254
G47.9
ICD-10 Finland
Sleep disorder, unspecified
2.3
6.1
46
208
JDF01
NOMESCO Finland
Laparoscopic gastroplasty
8.6
6.1
12
14
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
3.6
6.0
19
53
H47.2
ICD-10 Finland
Optic atrophy
10.1
6.0
11
11
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.7
6.0
31
117
M79.7
ICD-10 Finland
Fibromyalgia
3.3
6.0
22
68
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
3.4
6.0
21
63
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.1
6.0
52
249
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
357
265
18.38
307.65
2.0
1.5
5.40
12.25
iu/l
7.81
275
213
712
953
15.80
307.65
3.2
2.3
347.50
364.95
nmol/l
1.53
665
896
802
880
23.17
307.65
3.8
1.9
181.78
224.00
pmol/l
14.42
785
843
1107
2428
29.50
307.65
8.0
2.3
11.38
14.95
nmol/l
47.05
1060
2275
867
1080
23.34
307.65
3.9
1.9
26.85
36.48
nmol/l
34.88
831
1052
401
106
54.92
307.65
2.0
2.4
18.42
20.54
nmol/l
1.40
368
100
780
524
37.22
307.65
2.3
1.4
3.53
5.14
u/l
6.05
591
425
573
410
24.72
307.65
2.6
1.5
268.66
259.58
mu/l
0.22
559
385
226
126
21.62
288.40
2.2
1.5
443.15
298.43
mu/l
0.55
164
105
195
109
20.97
247.65
2.1
1.6
0.13
0.25
nmol/l
1.32
139
81
142
69
23.06
190.75
1.5
1.4
4.40
13.58
u/l
3.54
92
58
1085
6191
6.29
136.95
5.6
3.9
1.19
1.70
ug/l
10.50
1010
5750
1139
7248
6.74
112.97
5.7
3.3
14.56
14.69
pmol/l
1.01
1084
6747
157
256
6.86
94.19
1.7
1.4
152.32
212.85
pmol/l
0.95
157
256
198
479
4.72
76.77
2.6
3.8
4.59
4.74
pmol/l
1.04
172
445
1208
9162
8.07
71.08
6.8
4.0
1.79
1.82
mu/l
0.53
1145
8622
56
32
18.26
69.14
1.4
1.2
5.84
5.57
umol/l
0.11
34
25
699
3992
2.68
63.86
3.0
2.5
74.22
70.94
nmol/l
2.41
644
3723
745
4425
2.66
62.26
7.2
8.9
1.21
1.20
mmol/l
1.13
622
3904
795
4899
2.68
61.19
4.2
3.4
22.31
21.01
%
1.24
288
1774
707
4258
2.50
54.85
3.3
2.9
148.53
179.37
ug/l
2.74
675
4070
110
217
5.46
53.65
1.2
1.3
42.06
34.56
u/l
0.09
91
191
53
45
12.25
52.59
1.9
1.3
5.55
1.57
nmol/l
0.61
42
39
1041
7772
2.92
47.84
8.5
8.8
73.52
77.53
u/l
1.46
1004
7507
651
3952
2.33
47.19
6.9
8.3
1.21
1.20
mmol/l
0.94
602
3738
633
3819
2.32
46.28
3.3
2.6
0.55
0.66
ug/l
4.77
332
1946
995
7359
2.65
44.73
4.6
4.0
7.40
8.67
mm/h
3.29
950
7007
88
168
5.55
44.38
1.1
1.1
—
—
—
0
0
250
1034
2.77
40.97
5.2
4.3
27.72
28.50
%
0.48
187
749
327
1547
2.50
40.73
2.4
2.8
16.18
14.47
umol/l
3.63
309
1471
609
3768
2.19
40.07
2.2
1.9
100.18
95.64
pmol/l
1.78
343
2224
312
1462
2.51
39.53
2.4
2.7
2.54
2.32
g/l
10.92
297
1381
292
1357
2.50
37.45
2.4
2.8
25.90
25.43
%
0.24
276
1299
189
714
2.94
36.44
2.6
3.7
5.26
5.14
kpa
1.51
183
692
580
3625
2.11
36.03
6.0
3.8
9.92
9.42
mmol/l
1.31
498
3213
752
5193
2.10
35.57
6.1
7.6
12.48
12.66
umol/l
0.08
718
5027
830
5956
2.14
35.36
5.8
6.0
6.69
6.79
mmol/l
0.69
799
5713
1198
10209
4.28
34.11
8.0
5.5
39.68
38.94
mmol/mol
2.06
1155
9847
1223
10594
5.65
33.59
20.5
16.2
139.71
139.73
mmol/l
0.08
1209
10421
163
597
2.99
33.09
2.4
3.7
1.26
1.53
mmol/l
0.61
132
455
1225
10649
5.75
32.92
20.7
16.3
4.00
4.00
mmol/l
0.00
1208
10462
627
4170
2.00
31.48
5.1
6.2
37.80
36.86
g/l
4.25
590
3977
120
387
3.32
30.15
2.6
4.3
24.97
24.84
mmol/l
0.26
112
367
1176
10062
3.40
29.93
6.2
4.4
6.03
5.99
mmol/l
0.45
1124
9513
1197
10389
3.83
28.95
16.5
13.1
87.63
90.36
ml/min/173m2
5.43
1136
9583
485
3019
1.98
28.76
2.4
2.4
201.46
366.39
u/l
2.32
463
2897
143
538
2.87
27.49
2.1
2.2
38.51
39.77
u/l
0.31
136
495
576
3845
1.91
27.39
3.6
3.3
38.35
43.82
ng/l
0.16
412
2450
137
513
2.87
26.54
1.2
1.2
55.77
117.17
u/ml
2.14
43
174
504
3263
1.91
25.94
2.7
3.0
52.81
61.02
u/l
3.88
467
3112
491
3164
1.90
25.54
4.3
4.4
5.29
9.10
mg/mmol
1.42
339
2205
308
1691
2.09
25.41
1.6
1.7
63100062.72
14787721.04
pmol/l
0.52
271
1481
443
2822
1.88
23.42
2.9
3.7
2.34
2.35
mmol/l
1.19
406
2635
577
3991
1.82
23.37
3.7
3.9
37.84
38.12
u/l
0.03
552
3786
153
649
2.54
23.13
4.4
4.5
1.22
1.22
mmol/l
1.23
140
580
614
4348
1.80
22.81
12.2
12.1
1.17
1.19
inr
0.66
530
3619
224
1143
2.17
22.08
1.9
1.7
1214.70
1131.44
nmol/l
0.77
175
917
774
5920
1.79
21.67
8.6
11.2
4.17
4.12
e9/l
0.23
702
5181
1185
10539
2.97
21.13
5.8
4.1
1.69
1.46
mmol/l
13.69
1141
10057
342
2066
1.90
20.91
2.3
2.2
3.07
2.71
mg/l
2.07
296
1820
371
2345
1.82
19.43
1.4
1.3
1.43
2.18
u/ml
0.75
128
698
680
5114
1.71
19.20
3.4
3.2
0.00
0.00
estimate
-0.00
176
1023
375
2390
1.81
19.04
2.7
3.2
501.54
998.25
ng/l
3.61
272
1948
1184
10624
2.79
18.86
17.5
14.3
20.87
24.61
mg/l
3.98
1029
8629
683
5166
1.70
18.67
3.4
3.2
19.65
7.72
estimate
0.50
175
1016
93
343
2.85
18.44
1.9
2.4
8.03
10.95
mg/l
2.82
87
329
683
5178
1.69
18.41
3.5
3.2
0.07
0.01
estimate
0.59
153
920
193
998
2.10
18.17
7.2
6.1
—
—
—
0
0
403
2664
1.75
17.86
3.2
3.4
0.00
0.01
estimate
0.96
166
927
1249
11625
6.88
17.70
14.9
11.2
37.95
33.76
u/l
4.50
1236
11423
1211
11047
3.25
17.68
6.9
4.7
1.17
1.28
mmol/l
25.96
1168
10600
348
2210
1.79
17.68
1.9
1.6
18.31
18.54
nmol/l
0.12
297
1965
1248
11615
6.54
17.54
22.7
17.2
87.15
82.69
umol/l
3.93
1237
11532
1217
11149
3.41
17.31
7.3
5.2
2.72
2.85
mmol/l
5.47
1175
10701
1212
11081
3.24
17.23
6.9
4.8
4.47
4.66
mmol/l
9.84
1177
10671
1260
12078
11.93
17.18
29.5
20.7
241.69
242.62
e9/l
0.22
1254
11896
187
975
2.08
17.17
2.6
2.6
10.52
10.76
g/l
0.32
136
902
56
160
3.62
16.93
2.1
2.2
5.41
5.61
mmol/24h
0.16
50
148
1260
12088
11.72
16.85
29.4
20.7
4.99
4.79
e12/l
29.36
1252
11892
1260
12093
11.61
16.69
29.5
20.8
6.85
6.63
e9/l
4.36
1251
11891
628
4743
1.64
16.47
2.2
1.9
1.80
1.58
mmol/l
4.53
524
4203
710
5564
1.63
15.78
3.9
3.6
12.89
72.76
e6/l
—
9
74
50
141
3.65
15.42
1.5
1.5
0.16
0.35
nmol/l
—
5
10
616
4696
1.61
15.08
14.1
11.7
0.00
0.00
e9/l
0.00
539
3875
1014
8799
1.77
14.39
4.7
3.6
52.17
53.33
u/l
0.23
981
8518
144
727
2.11
14.31
2.6
2.4
11.66
17.62
au/ml
0.53
19
99
421
2965
1.63
14.02
2.7
2.8
370.31
368.58
umol/l
0.15
381
2755
429
3062
1.61
13.39
2.9
2.6
0.00
0.02
estimate
0.83
136
803
135
684
2.09
13.27
1.5
1.3
62.74
53.77
au/ml
—
9
52
536
4053
1.56
12.94
3.4
3.0
0.01
0.00
estimate
0.13
140
879
97
440
2.30
12.54
2.2
3.5
1.16
1.39
mg/l
2.81
83
417
328
2224
1.64
12.47
1.8
1.5
2.54
2.56
g/l
0.06
233
1562
339
2353
1.60
11.59
2.0
1.9
0.63
1.11
mg/l
7.33
256
1738
227
1424
1.72
11.49
2.3
3.1
115.87
156.14
ug/g
1.39
192
1214
40
119
3.44
11.43
1.5
1.4
0.15
0.18
nmol/l
1.76
34
103
94
447
2.19
10.86
1.5
1.9
5.89
4.84
mg/l
0.17
70
328
218
1380
1.70
10.62
6.4
8.2
1.00
1.02
mmol/l
0.50
210
1316
63
256
2.54
10.39
1.2
1.3
3.75
3.78
mmol/l
0.07
56
242
21
24
8.88
10.29
2.0
1.4
76.14
116.08
nmol/24h
0.79
21
24
242
1592
1.64
10.15
2.4
2.2
—
—
—
0
0
248
1645
1.63
10.06
1.4
1.3
13.32
27.50
iu/ml
3.76
62
457
255
1720
1.60
9.62
2.4
2.3
—
—
—
0
0
70
313
2.31
9.39
1.9
2.2
—
—
—
0
0
42
146
2.94
9.34
1.4
1.5
314.75
330.44
pmol/l
0.12
36
128
51
198
2.64
9.24
1.2
1.2
156.00
386.15
titre
—
5
13
144
850
1.78
8.93
2.0
1.9
0.22
0.36
mg/l
2.79
68
486
328
2385
1.51
8.76
2.2
2.0
1.42
1.50
%
1.66
282
2161
66
297
2.29
8.74
1.6
1.9
—
—
—
0
0
219
1473
1.59
8.27
1.4
1.3
4.11
8.85
u/ml
0.82
94
641
103
565
1.90
8.08
3.7
5.3
92.45
92.52
ng/l
0.00
88
516
534
4314
1.41
8.03
2.8
2.8
—
—
estimate
—
0
0
162
1021
1.67
7.93
3.8
4.7
2.04
1.81
mmol/l
0.42
142
887
166
1055
1.66
7.87
3.8
4.6
5.99
5.87
kpa
0.95
158
1031
21
53
4.01
7.63
1.1
1.2
213.24
211.51
mmol/24h
0.01
21
53
290
2113
1.48
7.53
2.7
2.7
1.72
2.95
e6/l
6.07
271
1941
72
360
2.06
7.37
1.3
1.2
0.28
0.85
u/ml
—
6
26
141
880
1.68
7.16
3.4
4.0
4.76
4.73
kpa
0.05
133
856
81
428
1.95
7.12
3.3
4.1
25.21
25.12
mmol/l
0.09
75
412
210
1449
1.54
7.03
2.8
3.3
2.41
2.43
mmol/l
2.29
193
1312
12
12
10.08
6.54
1.5
1.5
1.66
1.51
%
0.50
12
12
18
34
5.35
6.47
3.0
2.8
—
—
—
0
0
115
699
1.71
6.44
3.0
3.0
68.09
67.38
g/l
0.52
108
670
396
3136
1.38
6.34
3.6
3.3
31.66
78.34
e6/l
1.08
320
2401
54
260
2.12
6.14
1.4
1.5
740.36
1718.08
e6/l
0.51
47
196
118
735
1.67
6.04
1.7
1.3
123.53
328.94
u/ml
2.77
108
691
53
255
2.13
6.04
1.3
1.5
45.49
17.85
e6/l
0.56
41
178
22
69
3.23
5.88
1.2
1.2
115.73
109.32
pmol/l
0.20
22
69
107
657
1.69
5.79
3.1
4.0
143.49
136.20
g/l
1.95
100
642
153
1035
1.54
5.58
6.9
9.7
8.62
8.58
mmol/l
0.03
145
1001
88
521
1.74
5.44
1.0
1.1
—
—
—
0
0
171
1194
1.50
5.38
7.0
11.0
1.33
0.83
mmol/l
1.12
148
1010
238
1774
1.42
5.33
3.8
4.5
0.84
0.82
mmol/l
1.74
224
1699
21
69
3.08
5.23
1.6
1.4
1.65
1.32
nmol/l
0.60
15
54
292
2261
1.38
5.22
2.4
2.6
—
—
—
0
0
22
76
2.93
5.05
1.7
2.9
14.67
20.49
mg/l
—
6
35
294
2296
1.37
4.96
3.2
3.1
1.02
1.02
kg/l
0.51
196
1486
69
396
1.79
4.77
1.9
1.7
—
—
—
0
0
27
108
2.53
4.73
4.1
4.2
—
—
—
0
0
202
1495
1.42
4.68
2.4
2.0
—
—
—
0
0
12
22
5.50
4.60
1.1
1.1
—
—
—
0
0
81
493
1.69
4.57
1.4
1.5
—
—
—
0
0
65
374
1.78
4.48
1.5
1.7
10.05
14.47
u/ml
0.36
16
122
21
76
2.79
4.46
1.1
1.6
—
—
—
0
0
14
32
4.41
4.44
2.9
1.9
62.64
52.42
ug/l
0.23
14
32
333
2695
1.32
4.36
3.6
3.2
0.31
0.35
e6/l
0.15
258
1956
146
1031
1.47
4.35
2.6
2.7
0.23
0.23
g/l
0.23
139
959
42
215
1.99
4.15
1.3
2.1
1.85
3.63
iu/l
2.35
13
91
111
748
1.53
4.15
7.6
12.1
25.23
24.92
mmol/l
0.47
111
743
46
246
1.90
4.02
7.2
6.6
352.38
371.79
umol/l
0.42
40
217
26
111
2.37
4.01
2.4
2.6
6.80
7.48
mmol/l
0.60
21
101
45
239
1.92
4.01
1.0
1.1
84.69
100.66
iu/ml
—
10
61
49
268
1.86
4.00
2.2
2.1
—
—
—
0
0
50
277
1.84
3.93
2.4
2.1
—
—
—
0
0
38
192
2.01
3.91
1.2
1.6
—
—
—
0
0
37
186
2.02
3.86
2.7
2.3
—
—
—
0
0
21
83
2.56
3.81
2.0
1.9
—
—
—
0
0
44
237
1.89
3.78
1.5
1.6
—
—
—
0
0
24
103
2.36
3.68
1.1
1.1
—
—
—
0
0
19
74
2.59
3.56
1.2
1.1
1.10
1.06
u/l
—
9
34
25
112
2.26
3.49
1.7
1.8
—
—
—
0
0
25
112
2.26
3.49
1.7
1.8
—
—
—
0
0
155
1153
1.39
3.49
5.7
5.2
218.43
238.00
u/l
2.71
144
1112
858
7930
1.25
3.47
3.1
3.1
—
—
—
0
0
42
230
1.85
3.45
2.5
2.3
142.47
137.73
g/l
0.55
32
180
41
228
1.82
3.23
1.5
1.2
2.10
8.43
u/ml
—
6
23
325
2716
1.26
3.22
4.7
4.9
93.32
89.79
%
1.93
316
2685
31
157
2.00
3.21
1.3
1.5
1.07
1.47
promille
0.97
25
127
14
49
2.88
3.19
1.6
1.6
—
—
—
0
0
24
111
2.18
3.14
1.8
1.8
—
—
—
0
0
29
145
2.02
3.12
1.1
1.1
—
—
—
0
0
48
284
1.72
3.09
1.5
1.5
286.44
262.18
ug/g
0.32
28
167
59
370
1.62
3.06
1.3
1.3
—
—
—
0
0
5
5
10.03
2.98
1.0
1.0
—
—
—
0
0
24
114
2.13
2.95
1.7
1.8
—
—
—
0
0
61
390
1.59
2.93
1.7
1.7
9.57
5.06
iu/ml
0.52
15
96
38
215
1.79
2.86
3.4
3.6
246.30
4802.98
u/l
—
6
63
24
116
2.09
2.84
1.8
1.7
—
—
—
0
0
24
116
2.09
2.84
1.8
1.8
—
—
—
0
0
46
276
1.69
2.84
1.5
1.4
—
—
—
0
0
25
123
2.05
2.82
1.9
2.4
—
—
—
0
0
109
793
1.41
2.82
1.6
1.5
—
—
—
0
0
45
271
1.68
2.75
1.2
1.4
—
—
—
0
0
8
19
4.23
2.68
1.0
1.1
—
—
—
0
0
52
798
0.64
2.64
1.1
1.1
0.75
0.71
ratio
—
6
68
20
93
2.17
2.61
2.1
2.1
13.45
14.16
%
0.18
20
93
25
127
1.99
2.61
1.6
1.9
—
—
—
0
0
38
222
1.73
2.60
1.5
1.7
—
—
—
0
0
55
827
0.65
2.55
1.1
1.1
1.28
1.42
g/l
6.54
55
827
25
129
1.96
2.51
1.0
1.1
—
—
—
0
0
12
45
2.68
2.45
1.7
1.7
13.11
16.19
umol/l
0.63
12
45
13
51
2.57
2.44
1.2
3.8
17.71
502.02
ug/l
0.50
13
44
17
76
2.25
2.44
1.5
1.3
0.36
1.50
u/ml
—
8
44
39
234
1.69
2.44
1.6
1.6
—
—
—
0
0
272
2294
1.24
2.44
1.7
1.5
—
—
—
0
0
26
138
1.90
2.42
2.5
1.9
—
—
—
0
0
9
27
3.35
2.39
1.0
1.2
—
—
—
0
0
20
97
2.08
2.38
2.0
1.2
—
—
—
0
0
22
111
2.00
2.36
2.0
2.5
—
—
—
0
0
91
665
1.40
2.34
1.9
1.8
—
—
—
0
0
29
162
1.81
2.32
1.1
1.2
—
—
—
0
0
124
954
1.33
2.31
3.9
3.2
—
—
—
0
0
7
185
0.37
2.29
1.3
1.7
953.20
917.08
mu/l
—
7
157
26
141
1.86
2.28
2.6
2.0
—
—
—
0
0
8
25
3.21
2.09
1.4
1.1
—
—
—
0
0
5
10
5.01
2.07
1.8
2.4
—
—
—
0
0
35
215
1.65
2.05
2.1
1.7
—
—
—
0
0
30
177
1.71
2.03
1.0
1.1
6.39
2.03
eliau/ml
0.86
17
90
46
303
1.54
2.03
1.2
1.1
5.19
2.05
u/ml
0.72
26
167
14
63
2.24
2.01
1.4
1.1
—
—
—
0
0
5
11
4.56
1.94
1.8
2.4
—
—
—
0
0
42
275
1.55
1.91
4.8
2.3
0.31
0.96
g/l
1.50
36
251
13
58
2.25
1.91
1.1
1.2
—
65.17
%
—
0
6
104
805
1.32
1.89
2.3
2.6
79.73
74.51
ml/min/173m2
0.73
48
323
82
613
1.36
1.88
2.6
2.9
—
—
—
0
0
40
261
1.55
1.86
2.2
2.4
258.12
139.33
ug/min
0.25
26
160
51
351
1.47
1.85
2.2
3.0
—
—
—
0
0
40
263
1.54
1.80
1.1
1.1
1.78
1.17
u/ml
0.20
15
122
7
23
3.05
1.80
1.0
1.8
—
—
—
0
0
6
18
3.34
1.75
1.0
1.3
—
—
—
0
0
6
18
3.34
1.75
1.0
1.2
—
—
—
0
0
28
170
1.66
1.74
2.0
1.6
—
—
—
0
0
7
24
2.93
1.72
1.0
1.1
—
—
—
0
0
5
13
3.86
1.71
1.0
1.4
—
—
—
0
0
58
418
1.41
1.68
1.9
1.9
1.56
1.50
g/l
0.19
51
371
44
301
1.48
1.67
1.3
2.4
1.02
0.94
nmol/l
0.32
37
274
44
301
1.48
1.67
1.9
1.8
—
—
—
0
0
14
69
2.04
1.65
1.0
1.1
—
—
—
0
0
10
41
2.45
1.64
2.2
2.0
27.90
28.88
%
—
10
41
17
91
1.88
1.61
1.4
1.1
—
—
—
0
0
157
1308
1.23
1.60
2.7
3.4
7.15
9.00
umol/l
0.87
142
1173
40
271
1.49
1.60
1.1
1.1
4.07
6.57
u/ml
0.80
19
159
32
207
1.56
1.58
2.0
1.5
—
—
—
0
0
8
33
2.43
1.54
1.0
1.2
42.30
40.62
g/l
—
8
33
5
15
3.34
1.52
1.2
1.2
—
—
—
0
0
16
86
1.87
1.50
3.7
3.1
469.55
641.78
e6/l
0.44
11
74
9
37
2.44
1.48
2.6
3.8
—
—
—
0
0
9
37
2.44
1.48
2.6
3.8
—
—
—
0
0
9
37
2.44
1.48
2.6
3.8
—
—
—
0
0
69
525
1.33
1.46
2.6
2.9
—
—
—
0
0
15
80
1.89
1.45
2.6
1.8
—
—
—
0
0
37
253
1.48
1.44
1.6
1.6
12188.59
12029.52
e6/l
0.01
27
178
15
81
1.86
1.40
1.5
1.3
0.50
0.55
ratio
—
7
39
37
256
1.46
1.37
2.1
1.6
—
—
—
0
0
9
41
2.20
1.37
1.0
1.1
—
—
—
0
0
19
113
1.69
1.32
1.6
2.8
33.11
33.61
pg
0.34
19
113
15
83
1.82
1.31
2.3
2.3
852.63
647.39
ml
—
8
54
14
76
1.85
1.30
1.4
1.2
—
—
—
0
0
5
18
2.78
1.28
1.0
1.3
—
—
—
0
0
11
55
2.01
1.27
1.0
1.0
951.45
873.83
ng/l
0.34
11
40
11
55
2.01
1.27
1.0
1.0
21.91
25.54
ng/l
0.28
11
37
8
35
2.29
1.27
1.4
3.1
82.75
137.81
ng/l
—
8
35
11
56
1.97
1.22
1.0
1.0
174.00
203.60
ng/l
0.50
11
42
43
314
1.38
1.21
1.2
1.1
3.84
3.51
—
8
75
12
64
1.88
1.18
2.8
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
64
1.88
1.18
1.0
1.1
—
—
—
0
0
16
94
1.71
1.17
1.2
1.3
7391.29
74963.29
e6/l
—
7
70
15
87
1.73
1.15
2.1
2.4
—
—
—
0
0
15
87
1.73
1.15
2.1
2.4
—
—
—
0
0
15
87
1.73
1.15
2.1
2.4
—
—
—
0
0
36
259
1.40
1.12
1.6
1.4
—
—
—
0
0
23
151
1.53
1.12
1.1
1.1
—
—
—
0
0
5
21
2.39
1.09
2.2
2.0
—
—
—
0
0
36
261
1.39
1.08
6.7
3.4
29.09
43.65
mg/l
0.85
31
212
36
262
1.39
1.06
6.7
3.4
33.82
67.80
mg/l
0.79
30
212
9
46
1.96
1.03
1.7
1.6
—
—
—
0
0
9
46
1.96
1.03
1.7
1.6
—
—
—
0
0
13
75
1.74
1.03
1.4
1.2
—
—
—
0
0
18
114
1.59
1.03
1.6
1.5
—
—
—
0
0
25
171
1.47
1.02
5.4
4.4
7.52
11.54
pmol/l
0.90
25
171
9
47
1.92
1.02
2.6
3.3
—
—
—
0
0
9
47
1.92
1.02
2.6
3.3
—
—
—
0
0
9
47
1.92
1.02
2.6
3.3
—
—
—
0
0
9
47
1.92
1.02
2.6
3.3
—
—
—
0
0
21
139
1.52
1.00
1.0
1.1
272.90
272.64
mg/l
0.00
21
130
78
640
1.23
0.99
10.6
14.2
17.49
16.75
%
1.40
78
620
9
49
1.84
0.98
1.2
1.4
—
—
—
0
0
5
23
2.18
0.98
1.2
1.4
38.94
28.87
nmol/l
—
5
18
10
54
1.86
0.96
1.6
1.5
—
—
—
0
0
12
69
1.75
0.96
2.8
1.8
—
—
—
0
0
7
37
1.90
0.94
1.1
1.2
—
70.00
—
0
5
123
1061
1.18
0.93
2.7
3.2
31.35
83.17
u/l
0.64
109
950
10
55
1.82
0.92
1.6
1.5
—
—
—
0
0
26
184
1.42
0.92
3.9
3.0
17.30
26.24
mg/l
1.20
20
125
130
1132
1.17
0.89
2.4
1.8
—
—
—
0
0
6
30
2.00
0.87
1.0
1.4
—
—
—
0
0
19
128
1.49
0.86
6.7
6.3
12.00
8.21
%
1.47
19
128
19
128
1.49
0.86
3.4
3.1
33.68
44.20
%
1.32
19
128
6
32
1.88
0.82
1.5
1.2
—
—
—
0
0
28
206
1.37
0.81
1.0
1.0
0.00
0.41
u/ml
—
5
78
19
130
1.47
0.81
1.2
1.4
—
—
—
0
0
0
24
0.00
0.79
0.0
4.0
—
97.71
—
0
24
177
1591
1.13
0.79
3.7
3.1
1.25
0.66
e6/l
0.47
100
758
29
216
1.35
0.79
1.1
1.1
1.65
4.10
u/ml
1.02
11
110
6
33
1.82
0.79
1.0
1.2
—
—
—
0
0
22
156
1.42
0.79
1.2
1.5
—
—
—
0
0
16
234
0.68
0.78
1.4
1.5
—
—
—
0
0
23
165
1.40
0.78
1.1
1.1
2.27
2.78
—
6
42
35
270
1.30
0.76
1.0
1.1
—
—
—
0
0
15
99
1.52
0.75
2.3
3.0
—
—
—
0
0
215
1966
1.11
0.73
4.3
3.7
1461.14
640.53
ng/l
0.59
152
1465
72
609
1.19
0.72
2.6
3.0
115.04
141.83
ng/l
0.28
54
528
10
60
1.67
0.72
1.0
1.1
181.17
261.95
iu/ml
—
10
60
35
273
1.29
0.72
1.0
1.1
—
—
—
0
0
30
229
1.32
0.71
1.1
1.0
3.54
2.25
u/ml
—
10
127
7
42
1.67
0.68
1.4
1.1
—
—
—
0
0
7
43
1.63
0.67
1.0
1.3
—
—
—
0
0
63
532
1.19
0.66
1.9
1.6
—
—
—
0
0
19
137
1.39
0.64
1.1
1.1
—
—
—
0
0
34
269
1.27
0.64
1.1
1.1
3.51
2.01
u/ml
0.19
13
140
46
379
1.22
0.62
1.2
1.3
91.31
220.57
miu/ml
1.73
13
170
10
63
1.59
0.62
3.1
1.8
—
—
—
0
0
121
1083
1.13
0.61
2.5
1.9
—
—
—
0
0
10
64
1.57
0.58
1.2
2.0
179.50
202.08
u/l
—
10
64
33
264
1.26
0.58
2.8
3.1
3.00
2.26
index
0.32
17
156
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
186
1716
1.10
0.55
3.5
2.9
0.53
0.78
e6/l
1.12
108
888
6
37
1.62
0.55
1.2
1.2
—
—
—
0
0
59
507
1.17
0.53
1.2
1.3
—
—
—
0
0
6
40
1.50
0.51
1.2
1.2
—
17.00
—
0
9
30
368
0.81
0.50
2.4
4.6
11.50
3231.25
u/ml
0.65
24
321
11
76
1.45
0.48
5.4
2.6
606.80
142.53
umol/l
—
5
32
29
236
1.23
0.47
7.8
3.1
13.98
1.43
ratio
0.49
16
123
15
111
1.36
0.46
1.2
1.1
14.39
23.14
u/ml
—
8
43
7
49
1.43
0.46
1.0
1.2
—
—
—
0
0
209
1960
1.08
0.45
2.2
2.0
4.24
3.95
ratio
1.97
167
1526
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
16
122
1.32
0.42
1.0
1.2
—
—
—
0
0
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
5
32
1.56
0.42
3.2
6.9
5.32
5.42
kpa
—
5
32
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
28
232
1.21
0.40
1.1
1.1
—
—
—
0
0
5
35
1.43
0.39
1.4
1.3
5.87
6.70
mmol/l
—
5
35
5
35
1.43
0.39
2.6
4.4
4.97
4.91
kpa
—
5
35
5
35
1.43
0.39
2.6
4.4
11.70
10.12
kpa
—
5
35
23
188
1.23
0.37
1.3
1.2
—
—
—
0
0
9
69
1.31
0.37
1.2
1.3
—
—
—
0
0
14
108
1.30
0.35
3.2
4.2
—
—
—
0
0
155
1456
1.07
0.34
2.0
1.7
3.46
3.61
mmol/l
0.85
111
994
6
47
1.28
0.32
1.3
2.0
—
—
—
0
0
6
47
1.28
0.32
1.3
2.0
—
—
—
0
0
26
220
1.19
0.32
1.3
1.3
5.08
3.79
u/ml
0.29
13
117
71
776
0.91
0.30
3.0
5.3
38.68
20.38
ug/l
0.22
50
639
10
75
1.34
0.30
1.1
1.2
4.00
8.11
mm/h
—
10
75
10
77
1.30
0.26
1.2
1.1
1382.60
1393.39
miu/ml
—
10
77
37
332
1.12
0.23
1.4
1.6
—
14.69
—
0
7
11
88
1.25
0.22
1.5
1.1
—
—
—
0
0
5
41
1.22
0.22
1.4
1.4
6.76
8.26
ug/l
—
5
41
5
42
1.19
0.21
2.8
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
6.32
—
0
10
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
0
12
0.00
0.21
0.0
6.1
—
510.83
—
0
12
5
43
1.16
0.21
1.4
2.5
—
—
—
0
0
5
43
1.16
0.21
3.8
4.7
—
—
—
0
0
5
43
1.16
0.21
2.8
3.6
0.60
1.19
%
—
5
43
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
19
219
0.87
0.20
3.6
4.2
2.97
112.51
u/ml
0.83
19
213
6
52
1.15
0.19
1.2
1.3
394.00
651.93
u/l
—
6
46
87
825
1.06
0.17
1.9
2.2
5.20
10.09
ug/l
3.43
76
758
32
350
0.91
0.16
1.3
1.3
248.85
254.17
u/ml
0.04
20
219
9
79
1.14
0.15
1.0
1.2
—
—
—
0
0
34
313
1.09
0.15
1.4
1.6
105.17
144.67
au/ml
—
6
95
22
201
1.10
0.11
1.2
1.2
—
—
—
0
0
7
67
1.05
0.08
4.3
3.4
1.43
0.96
index
—
7
67
18
168
1.07
0.06
1.4
1.2
—
—
—
0
0
18
168
1.07
0.06
1.4
1.2
—
—
—
0
0
22
208
1.06
0.05
1.2
1.1
21.01
12.61
au/ml
—
9
77
58
565
1.03
0.04
1.5
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
318
1.04
0.04
5.3
3.3
0.31
0.31
iu/ml
0.01
17
167
10
92
1.09
0.03
4.3
3.6
1880.10
999.72
mg
—
10
92
10
99
1.01
0.00
3.0
2.1
—
—
—
0
0
23
227
1.01
0.00
1.3
1.3
9.13
5.75
u/ml
—
8
84
45
445
1.01
0.00
1.5
1.6
0.01
0.31
iu/ml
—
9
79
0
5
0.00
0.00
0.0
1.0
—
1.60
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
13.11
—
0
5
0
5
0.00
0.00
0.0
1.0
—
54.60
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
10.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
96
0.94
-0.00
2.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
423.67
—
0
6
0
8
0.00
-0.00
0.0
3.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
8
80
1.00
-0.00
1.1
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
—
—
0
0
7
76
0.92
-0.00
1.1
1.2
—
—
—
0
0
7
72
0.97
-0.00
1.1
1.2
—
—
—
0
0
7
76
0.92
-0.00
1.1
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
15.8
—
—
—
0
0
7
73
0.96
-0.00
1.0
1.2
—
—
—
0
0
7
76
0.92
-0.00
1.1
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: E4_HYPOGONADOTROPIC_HYPOGONADISM – Hypogonadotropic hypogonadism
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).